Metoclopramide Baxter

Metoclopramide, the active ingredient in Metoclopramide Baxter, is a dopamine antagonist presented as an injectable solution for intramuscular or intravenous use. It is employed to treat nausea and vomiting, gastroparesis, and postoperative nausea in adult patients.

GNH USA supplies Metoclopramide Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide acts on the dopaminergic pathways that trigger nausea and impair gastric motility. - Nausea and vomiting: reduces frequency and severity of episodes in various clinical settings. - Gastroparesis: enhances gastric emptying and alleviates related symptoms. - Postoperative nausea: prevents or treats nausea and vomiting following surgical procedures.

Metoclopramide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Restlessness: agitation or an inability to stay still. - Diarrhea: loose or frequent stools. - Headache: mild to moderate pain in the head. - Insomnia: difficulty falling or staying asleep. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Extrapyramidal symptoms: involuntary muscle movements or rigidity. - Tardive dyskinesia: persistent, irreversible facial or tongue movements. - Neuroleptic malignant syndrome: life‑threatening fever and muscle rigidity. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Depression or suicidal thoughts: mood changes requiring immediate attention. - Cardiac arrhythmias: irregular heart rhythms in susceptible individuals.

Metoclopramide requires careful consideration in several clinical situations. - Renal impairment: assess kidney function and adjust dose if necessary. - Elderly patients: monitor closely for extrapyramidal effects and sedation. - History of seizure disorders: use with caution as the drug may lower seizure threshold. - Concurrent antipsychotics: increased risk of movement disorders. - Pregnancy and lactation: safety not established; avoid unless benefits outweigh risks. - Store at room temperature: keep in original container, protect from moisture and light.

Metoclopramide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): additive dopamine blockade may worsen movement disorders. - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): increase metoclopramide plasma concentrations. - Monoamine oxidase inhibitors: risk of hypertensive reactions.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., opioids, benzodiazepines): enhanced sedation or respiratory depression. - Diuretics: may exacerbate electrolyte disturbances. - Other antiemetics (e.g., ondansetron): additive anti‑nausea effect may increase side‑effect burden.